Help with Prescribing MOUD

As of January 1, 2023, any clinician who has a DEA license that authorizes schedule III medications may prescribe buprenorphine.  For more information, see: https://www.samhsa.gov/medications-substance-use-disorders/removal-data-waiver-requirement

Other resources for initiating buprenorphine: 

CA Bridge: https://cabridge.org/

Center for Addiction Medicine and Policy Buprenorphine Induction Pathway: https://penncamp.org/clinical/buprenorphine-induction-pathway/

UCSF Substance Use Warmline is available to talk to an Experienced MOUD provider 9:00 am to 8:00 pm ET at 1-855-300-3595 or online at https://nccc.ucsf.edu/clinical-resources/substance-use-resources/

Additional training and technical assistance is offered through the Central East (HHS) Addiction Technology Transfer Center Network.  For more information, see:  https://attcnetwork.org/centers/central-east-attc/home